Skip to main content
. 2020 Mar 12;25(6):1292. doi: 10.3390/molecules25061292

Table 7.

The matrix of similarity for examining endpoints.

Similarity
Mutagenicity Anticancer Activity Blood–Brain Barrier
Mutagenicity 41 10 14
Anticancer activity 10 61 26
Blood–brain barrier 14 26 92
Dissimilarity
Mutagenicity 11 8 7
Anticancer activity 8 24 8
Blood–brain barrier 7 8 52